Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 154,900 shares, a decline of 27.2% from the November 15th total of 212,800 shares. Based on an average trading volume of 979,800 shares, the short-interest ratio is currently 0.2 days.
Reckitt Benckiser Group Stock Up 0.2 %
OTCMKTS:RBGLY traded up $0.02 on Friday, reaching $12.26. The stock had a trading volume of 229,072 shares, compared to its average volume of 861,540. The company has a 50-day moving average of $12.34 and a 200 day moving average of $11.74. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. Reckitt Benckiser Group has a 12-month low of $10.24 and a 12-month high of $15.03.
Analyst Ratings Changes
Several research firms recently weighed in on RBGLY. UBS Group upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th. Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday. Citigroup upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. Finally, Barclays raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. Three equities research analysts have rated the stock with a hold rating, one has given a buy rating and four have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy”.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- What is a SEC Filing?
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.